Age Alone Should Not Dictate Myeloma Treatment
A real-world study of 561 patients aged 65–75 finds that autologous stem cell transplantation and quadruplet therapy improve progression-free survival, ...
A real-world study of 561 patients aged 65–75 finds that autologous stem cell transplantation and quadruplet therapy improve progression-free survival, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.